Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
09/2010
09/10/2010WO2009094668A8 New 2,3,4,5-tetrahydro-1h-pyrido[ 4,3-b] indole compounds and methods of use thereof
09/10/2010CA2751548A1 Synthesis of (4as,7as)-octahydro-1h-pyrrolo[3,4-b]pyridine
09/09/2010US20100228030 Process for the preparation of intermediates of tetracyclic compounds
09/09/2010US20100227882 Clopidogrel salt and polymorphic forms thereof
09/09/2010US20100227881 1,7-naphthyridine derivatives as p38 map kinase inhibitors
09/09/2010US20100227880 Chemical compounds
09/09/2010US20100227800 Triazole derivatives as kinase inhibitors
09/09/2010US20100226881 PYRAZOLO[1,5-a]PYRIDINES AND THEIR USE IN CANCER THERAPY
09/08/2010EP2226323A1 New tetrahydropyrazolo[3,4-c]isoquinolin-5-amine derivatives
09/08/2010EP2225246A1 Benzomorphan compounds
09/08/2010EP2225245A2 N-phenyl-imidazoý1,2-a¨pyridine-2-carboxamide compounds, preparation thereof and therapeutic application thereof
09/08/2010EP2225244A1 Imidazoý1,2-a¨pyridine-2-carboxamide derivatives, preparation thereof and application thereof in therapeutics
09/08/2010EP2225243A2 Derivatives of n-heterocyclic-6-heterocyclic-imidazoýl,2- a¨pyridine-2-carboxamides, preparation thereof and therapeutic application thereof
09/08/2010EP2225242A2 Derivatives of n-heterocyclic-imidazoý1,2-a¨pyridine-2-carboxamides, preparation thereof and therapeutic application thereof
09/08/2010EP2225241A2 Derivatives of n-phenyl-imidazoý1,2-a¨pyridine-2-carboxamides, preparation thereof and therapeutic application thereof
09/08/2010EP2225240A2 Derivatives of 6-heterocyclic-imidazoýl,2-a¨pyrroine-2-carboxamides, preparation thereof and therapeutic application thereof
09/08/2010EP2225238A1 Derivatives of 6,7-dihydro-5h-imidazoý1,2- ¨imidazole-3- carboxylic acid amides
09/08/2010EP2225237A2 Organic compounds
09/08/2010EP2225236A2 Organic compounds
09/08/2010EP2225227A2 Compounds
09/08/2010EP2225223A2 Organic compounds
09/08/2010EP2225212A1 Novel carboxylic acid 4-phenylazo-phenyl ester derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
09/08/2010EP2225202A2 Process for the preparation of isoindole derivatives as well as a process for the preparation of their intermediates
09/08/2010EP1478624B1 Chemical compounds
09/08/2010EP1320531B1 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
09/08/2010EP1263759B1 Azaindoles
09/08/2010CN1798746B Reverse-turn mimetics and method relating thereto
09/08/2010CN1732154B Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
09/08/2010CN101827845A Cgrp antagonists
09/08/2010CN101827844A Imidazo [1,2-a] pyridine derivatives useful as ALK inhibitors
09/08/2010CN101827843A Method for producing pyrazole fused ring derivative
09/08/2010CN101827815A Spiroheterocyclic pyrrolidine dione derivatives useful as pesticides
09/08/2010CN101824043A Compositions useful as inhibitors of protein kinases
09/08/2010CN101824035A Pharmaceutical composition comprising a salt of mirtazapine
09/08/2010CN101824034A Imidazoquinoline compounds
09/08/2010CN101824027A Polysubstituted tetrahydroquinoline derivative with optical activity and synthetic method and use thereof
09/08/2010CN101823951A Process for the preparation of 2-ethyl-4,6-dimethylphenyl acetic acid
09/08/2010CN101822291A Human milk simulating dairy product and preparation method thereof
09/08/2010CN101125865B Chiral ruthenium complex and application of the same used as antineoplastic
09/08/2010CN101099756B Anti-tumor traditional Chinese medicinal composition and preparation method and medicinal preparation thereof
09/08/2010CN101080403B Novel hydantoin derivatives as metalloproteinase inhibitors
09/08/2010CN101018789B Pyrrolo[2,3-c]pyridine derivatives and processes for the preparation thereof
09/07/2010US7790893 incorporating indolium ring moiety substituted at 3-position improves spectral properties; for detection of ligands; hybridization probes
09/07/2010US7790891 reduction reaction with sulfonic acid chloride in presence of basic agent; proton pump inhibitors
09/07/2010US7790883 5-[[(2,3-difluorophenyl)methyl]thio]-7-[[(1R)-2-hydroxy-1-methylethyl]amino]-3-[2-(phenylsulfonyl)ethyl]thiazolo[4,5-d]pyrimidin-2-(3H)-one; protection of the thiazole nitrogen atom while reacting a 7- leaving group with an amine for an amination reaction to result in improved yields; efficiency
09/07/2010US7790740 administering chemokine receptor antagonist such as N-{(1S)-3-[3-endo-(5-Acetyl-2-methyl-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridin-1-yl)-8-azabicyclo[3.2.1]oct-8-yl]-1-(-3-fluorophenyl)propyl}acetamide, for the treatment of viral, bacterial and protozoa infections
09/07/2010US7790730 1-((3-(4-chlorophenyl)isoxazol-5-yl)methyl)-8-(2,3-difluorophenyl)-1H-purine, used treat or prevent viral infections such as hepatitis C virus (HCV)
09/07/2010US7790729 vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF), receptor antagonists, such as N-(3-Fluoro-4-(2- (thiophen-2-yl)thieno[3,2- b]pyridin-7- yloxy)phenylcarbamothio- yl)-2-phenylacetamide, used for treating angiogenesis-mediated cell proliferative diseases or as antitumor agents
09/07/2010US7790722 nicotinic receptor agonists such as 3-{[(1S,4S)-5-Methyl-2,5-diazabicyclo[2.2.1]hept-2-yl]carbonyl}-1,2-benzisothiazole, used for the treatment of brain disorders
09/07/2010US7790719 used for the treatment of cachexia and other weight loss disorders, such as those resulting from cancer, HIV, old age and anorexia nervosa
09/07/2010US7790716 fatty acid biosynthesis inhibitors such as E)-3-(6-aminopyridin-3-yl)-N-methyl-N-(1-methyl-1H-pyrrolo[2,3-b]pyridin-3-ylmethyl)acrylamide, used fro the treatment of bacterial infections; antibiotics
09/07/2010US7790713 Inhibitors of interleukin-1β converting enzyme
09/07/2010US7790712 and Mitogen-Activated Protein Kinase-Activated Protein kinase-2 (MAPKAP-k2 inhibitors, used for preventing or treating diseases and pathological conditions involving inflammation such as chronic inflammatory disease
09/07/2010US7790709 Heterocyclic compounds, methods of making them and their use in therapy
09/07/2010CA2454785C 4-oxoimidazolidine-2-spiropiperidine derivatives
09/02/2010WO2010099223A1 Lyotropic liquid crystal systems based on aromatic tetracarboxylic bisbenzoimidazole derivatives and methods for making
09/02/2010WO2010099039A1 Indole derivatives as crth2 receptor antagonists
09/02/2010WO2010098495A1 Imidazolylpyrazine derivatives
09/02/2010WO2010098490A1 Salt of tetrahydrotriazolopyridine derivative and crystal thereof
09/02/2010WO2010098487A1 Nitrogen-containing fused heterocyclic compounds and their use as beta amyloid production inhibitors
09/02/2010WO2010098332A1 Method for producing polycyclic compound and intermediate for same
09/02/2010WO2010097469A1 Novel dioxo-imidazolidine derivatives, which inhibit the enzyme soat-1, and pharmaceutical and cosmetic compositions containing them
09/02/2010WO2010097410A1 Novel bronchodilating diazaheteroaryls
09/02/2010WO2010097335A1 Imidazo [1, 2 -a] pyridines as jnk modulators
09/02/2010WO2010097172A1 New tetrahydropyrazolo[3,4-c]isoquinolin-5-amine derivatives
09/02/2010US20100222574 Cyclic anilino - pyridinotriazines
09/02/2010US20100222377 Bis-quaternary ammonium cyclophane compounds that interact with neuronal nicotinic acetylcholine receptors
09/02/2010US20100222374 Spirocyclic heterocyclic derivatives and methods of their use
09/02/2010US20100222352 Compounds and Methods for the Treatment of Viruses and Cancer
09/02/2010US20100222350 Phenyl, pyridine, quinoline, isoquinoline, naphthyridine and pyrazine derivatives
09/02/2010US20100222345 Novel compounds as antagonists or inverse agonists for opioid receptors
09/02/2010US20100222339 Thiazole pyrazolopyrimidines CRF1 receptor antagonists
09/02/2010US20100222330 New Compounds
09/02/2010US20100222326 New Heterocyclic Derivatives Useful For The Treatment of CNS Disorders
09/02/2010US20100222321 Inhibitors of akt activtiy
09/02/2010US20100222270 Heterocyclic compounds as crth2 receptor antagonists
09/02/2010US20100221213 Y-shape branched hydrophilic polymer derivatives, their preparation methods, conjugates of the derivatives and drug molecules, and pharmaceutical compositions comprising the conjugates
09/02/2010DE102008063992A1 Neue aliphatisch substituierte Pyrazolopyridine und ihre Verwendung New aliphatic substituted pyrazolopyridines and their use
09/02/2010CA2753696A1 Nitrogen-containing fused heterocyclic compounds and their use as beta amyloid production inhibitors
09/02/2010CA2752981A1 Indole derivatives as crth2 receptor antagonists
09/02/2010CA2751299A1 Novel dioxo-imidazolidine derivatives, which inhibit the enzyme soat-1, and pharmaceutical and cosmetic compositions containing them
09/02/2010CA2749702A1 Salt of tetrahydrotriazolopyridine derivative and crystal thereof
09/02/2010CA2749236A1 Imidazo [1,2-a] pyridines as jnk modulators
09/01/2010EP2222675A1 5-anilinoimidazopyridines and methods of use
09/01/2010EP2222674A1 Amino triazoles as pi3k inhibitors
09/01/2010EP2222661A2 Non-nucleoside reverse transcriptase inhibitors
09/01/2010EP2222639A1 Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders
09/01/2010EP2222638A2 Biaryl pde4 inhibitors for treating inflammation
09/01/2010EP2222166A1 Heterocyclic kinase inhibitors
09/01/2010EP2102205B1 Pyrido-pyrazine derivatives useful as herbicidal compounds
09/01/2010EP1709047B1 Azabenzofuran substituted thioureas as inhibitors of viral replication
09/01/2010EP1560488B1 Antibacterial agents
09/01/2010EP1558614B1 Pyridopyrrolizine and pyridoindolizine derivatives
09/01/2010EP1285651B1 Melanin concentrating hormone antagonists
09/01/2010CN1948298B Dopamine D3 acceptor portion agonist and its application
09/01/2010CN1939918B Production of midanping
09/01/2010CN101821266A Modulators of cystic fibrosis transmembrane conductance regulator
09/01/2010CN101817837A Carbapenem derivative containing azabicyclo
09/01/2010CN101817821A Fluorine-containing pyrromonazole [3, 4-b] quinoline compound and synthetic method thereof
09/01/2010CN101817820A Method for synthesizing moxifloxacin hydrochloride